PointClickCare & Pfizer Launches Real World Data Collaboration

💡 This post was automatically imported from HIT Consultant. You can find the original article here.
Author: HIT Consultant Media (Jasmine Pennic)

PointClickCare & Pfizer Launches Real World Data Collaboration

What You Should Know:

– PointClickCare announced a collaboration with Pfizer Inc. to provide real-world insights for vulnerable populations at high risk of age-related disorders (including Cachexia) – further enhancing PCC’s mission to protect and support the senior population.

– With coverage approaching 70% of the long-term and post-acute care (LTPAC) market, PointClickCare is uniquely positioned to provide life sciences companies, like Pfizer, with outcomes-based evidence through extensive longitudinal patient records. The continued collaboration between LTPAC and Life Sciences companies is powering this innovation. 

Why It Matters

Globally, the population is aging rapidly. Between 2015 and 2050, the proportion of the world’s population over age 60 will nearly double, from 12% to 22%. In the United States, the number of individuals older than age 65 is projected to peak at 95 million in 2060. Many older adults will need to spend time in a long-term care facility as they age, but older adults in long-term care facilities are often unable to participate in clinical trials. This lack of representation can limit the development of therapies aimed at addressing the unmet needs of this important population.

With access to the real-world data PointClickCare can provide, research and development teams can gain a deeper understanding of the long-term and post-acute care demographic, resulting in more data-enriched clinical trials and empirical evidence-based studies. To learn more about how our data is advancing care in the life sciences space, visit our website here.

The News Aggregator will pull the latest articles and news from around the internet to present them in one place for you to easily keep up to date on all things related to Medical Informatics.

You may also like...

Leave a Reply

Your email address will not be published. Required fields are marked *

Welcome to MediFormatica. The site is still under construction so there are some rough edges here and there, but I'll be adding new and exciting content every day. So enjoy it and come back again for more great stuff.